Data management in oncology clinical trials features multiple complexities, and choosing the right EDC system is essential.

WillScot offers an asymmetric opportunity with a ~13% FCF yield despite a ~40% decline. Discover the $45+ intrinsic value.

Embedding QHSSE into the DNA of an organization is not just about passing audits or meeting legal requirements. It is about ...

Within the fast-paced world of customer relationship management (CRM), accurate data is the foundation of success. Recent ...

Over the long term, quality shares have significantly outperformed the broader stock market. Quality shares have also ...

The life sciences industry faces many challenges, driving a critical need for rapid digital transformation with data-driven decision-making as the backbone for change. Data enables pharma companies to ...

We are seeing a real shift in how organizations think about sustainability and operational risk...Now they are understood as ...

But managing, leveraging and realising the commercial advantage of data is also hard. If fully leveraging data is difficult enough, the bar is only getting higher – with AI changing the game.

In today’s ACT Brief, we examine how the FDA’s CNPV Program is reshaping operational planning and accelerated submission ...

In this edition of Data Spotlight, we look at how short interest sharpens factor investing, how dividend forecasts aid ...